ICU Clinical Trials in Nashville, Tennessee
25 recruitingNashville, Tennessee
Showing 1–20 of 25 trials
Recruiting
DESTINY-PANTUMOUR04
Liver CancerEsophageal CancerPancreatic Cancer+24 more
AstraZeneca100 enrolled17 locationsNCT07124000
Recruiting
Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Stage IV Renal Cell Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8Large Cell Neuroendocrine Carcinoma+42 more
National Cancer Institute (NCI)314 enrolled579 locationsNCT03866382
Recruiting
Phase 1Phase 2
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+6 more
BeOne Medicines614 enrolled127 locationsNCT05006716
Recruiting
Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
AstraZeneca1,018 enrolled159 locationsNCT06549595
Recruiting
Not Applicable
Single Versus Dual Implant Fixation of Distal Femur Fractures
Articular Fractures
Wake Forest University Health Sciences144 enrolled16 locationsNCT06286670
Recruiting
Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Germ Cell TumorChildhood Extracranial Germ Cell TumorExtragonadal Embryonal Carcinoma+27 more
Children's Oncology Group1,780 enrolled630 locationsNCT03067181
Recruiting
Not Applicable
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Tricuspid RegurgitationTricuspid Valve InsufficiencyTricuspid Valve Disease
Edwards Lifesciences870 enrolled79 locationsNCT04097145
Recruiting
Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
AVB - Atrioventricular BlockFetal AVB
NYU Langone Health1,300 enrolled24 locationsNCT04474223
Recruiting
Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Mixed Phenotype Acute LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+2 more
Children's Oncology Group5,951 enrolled230 locationsNCT03959085
Recruiting
Phase 1Phase 2
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaChronic Lymphocytic Leukemia+8 more
Vironexis Biotherapeutics Inc.32 enrolled9 locationsNCT06533579
Recruiting
Phase 1
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Ovarian CancerEndometrial CancerGerm Cell Tumor+2 more
Xencor, Inc.282 enrolled16 locationsNCT06276491
Recruiting
Not Applicable
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III (RETURN-III)
ICUIntensive Care UnitCognitive Rehabilitation+1 more
VA Office of Research and Development160 enrolled2 locationsNCT04353804
Recruiting
Phase 3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
Refractory Follicular LymphomaFollicular LymphomaRelapsed/Refractory Follicular Lymphoma
Epizyme, Inc.612 enrolled229 locationsNCT04224493
Recruiting
Phase 1
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
High-grade B-cell LymphomaDLBCL - Diffuse Large B Cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+7 more
Poseida Therapeutics, Inc.120 enrolled17 locationsNCT06014762
Recruiting
Phase 1
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma ( FL)Mantle Cell Lymphoma (MCL)+2 more
LTZ Therapeutics, Inc.42 enrolled5 locationsNCT07121946
Recruiting
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
Atrial FibrillationVentricular Tachycardia
Vanderbilt University Medical Center200 enrolled1 locationNCT06647459
Recruiting
Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
Atrial FibrillationVentricular TachycardiaPremature Ventricular Contraction
Vanderbilt University Medical Center200 enrolled1 locationNCT06575881
Recruiting
Not Applicable
Trisol System EFS Study
Tricuspid Regurgitation
Trisol Medical30 enrolled7 locationsNCT04905017
Recruiting
Not Applicable
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
Refractory Ventricular Tachycardia
Thermedical, Inc.130 enrolled7 locationsNCT05337241
Recruiting
Phase 2
Treating Exacerbations of Asthma With Oral Montelukast in Children
Status Asthmaticus
Vanderbilt University Medical Center90 enrolled1 locationNCT05819541